Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill

被引:226
作者
Braun, Andrea [1 ]
Chang, Domingo [1 ]
Mahadevappa, Karthik [1 ]
Gibbons, Fiona K. [2 ]
Liu, Yan [3 ]
Giovannucci, Edward [3 ,4 ]
Christopher, Kenneth B. [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Publ Hlth, Div Pulm, Massachusetts Gen Hosp, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
VITAMIN-D DEFICIENCY; PROLONGED CRITICAL ILLNESS; MYOCARDIAL-INFARCTION; UNITED-STATES; ADMINISTRATIVE DATABASES; CARDIOVASCULAR-DISEASE; COMORBIDITY INDEX; OUTCOMES RESEARCH; CLINICAL-DATA; CO-MORBIDITY;
D O I
10.1097/CCM.0b013e318206ccdf
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: We hypothesized that deficiency in 25-hydroxyvitamin D before hospital admission would be associated with all-cause mortality in the critically ill. Design: Multicenter observational study of patients treated in medical and surgical intensive care units. Setting: A total of 209 medical and surgical intensive care beds in two teaching hospitals in Boston, MA. Patients: A total of 2399 patients, age >= 18 yrs, in whom 25-hydroxyvitamin D was measured before hospitalization between 1998 and 2009. Interventions: None. Measurements and Main Results: Preadmission 25-hydroxyvitamin D was categorized as deficiency in 25-hydroxyvitamin D (<= 15 ng/mL), insufficiency (16-29 ng/mL), and sufficiency (>= 30 ng/mL). Logistic regression examined death by days 30, 90, and 365 post-intensive care unit admission, in-hospital mortality, and blood culture positivity. Adjusted odds ratios were estimated by multivariable logistic regression models. Preadmission 25-hydroxyvitamin D deficiency is predictive for short-term and long-term mortality. At 30 days following intensive care unit admission, patients with 25-hydroxyvitamin D deficiency have an odds ratio for mortality of 1.69 (95% confidence interval of 1.28-2.23, p <. 0001) relative to patients with 25-hydroxyvitamin D sufficiency. 25-Hydroxyvitamin D deficiency remains a significant predictor of mortality at 30 days following intensive care unit admission following multivariable adjustment (adjusted odds ratio of 1.69, 95% confidence interval of 1.26-2.26, p < .0001). At 30 days following intensive care unit admission, patients with 25-hydroxyvitamin D insufficiency have an odds ratio of 1.32 (95% confidence interval of 1.02-1.72, p = .036) and an adjusted odds ratio of 1.36 (95% confidence interval of 1.03-1.79, p = .029) relative to patients with 25-hydroxyvitamin D sufficiency. Results were similar at 90 and 365 days following intensive care unit admission and for in-hospital mortality. In a subgroup analysis of patients who had blood cultures drawn (n = 1160), 25-hydroxyvitamin D deficiency was associated with increased risk of blood culture positivity. Patients with 25-hydroxyvitamin D insufficiency have an odds ratio for blood culture positivity of 1.64 (95% confidence interval of 1.05-2.55, p = .03) relative to patients with 25-hydroxyvitamin D sufficiency, which remains significant following multivariable adjustment (odds ratio of 1.58, 95% confidence interval of 1.01-2.49, p = .048). Conclusion: Deficiency of 25-hydroxyvitamin D before hospital admission is a significant predictor of short-and long-term all-cause patient mortality and blood culture positivity in a critically ill patient population. (Crit Care Med 2011; 39:671-677)
引用
收藏
页码:671 / 677
页数:7
相关论文
共 54 条
[41]   A comparison between the APACHE II and Charlson Index Score for predicting hospital mortality in critically ill patients [J].
Quach, Susan ;
Hennessy, Deirdre A. ;
Faris, Peter ;
Fong, Andrew ;
Quan, Hude ;
Doig, Christopher .
BMC HEALTH SERVICES RESEARCH, 2009, 9
[42]   Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data [J].
Quan, HD ;
Sundararajan, V ;
Halfon, P ;
Fong, A ;
Burnand, B ;
Luthi, JC ;
Saunders, LD ;
Beck, CA ;
Feasby, TE ;
Ghali, WA .
MEDICAL CARE, 2005, 43 (11) :1130-1139
[43]   Vitamin D and health in the 21st century: bone and beyond. Executive summary [J].
Raiten, DJ ;
Picciano, MF .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (06) :1673S-1677S
[44]   RESOURCE UTILIZATION AMONG INTENSIVE-CARE PATIENTS - MANAGED CARE VS TRADITIONAL INSURANCE [J].
RAPOPORT, J ;
GEHLBACH, S ;
LEMESHOW, S ;
TERES, D .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (11) :2207-2212
[45]  
SIBBALD W, 2001, UPDATE INTENSIVE CAR
[46]   Vitamin D: emerging new roles in insulin sensitivity [J].
Teegarden, Dorothy ;
Donkin, Shawn S. .
NUTRITION RESEARCH REVIEWS, 2009, 22 (01) :82-92
[47]   Incident acute coronary syndromes in chronic dialysis patients in the United States [J].
Trespalacios, FC ;
Taylor, AJ ;
Agodoa, LY ;
Abbott, KC .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1799-1805
[48]   The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone [J].
Van den Berghe, G ;
Baxter, RC ;
Weekers, F ;
Wouters, P ;
Bowers, CY ;
Iranmanesh, A ;
Veldhuis, JD ;
Bouillon, R .
CLINICAL ENDOCRINOLOGY, 2002, 56 (05) :655-669
[49]   Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness [J].
Van den Berghe, G ;
Wouters, P ;
Weekers, F ;
Mohan, S ;
Baxter, RC ;
Veldhuis, JD ;
Bowers, CY ;
Bouillon, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1311-1323
[50]   Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness [J].
Van den Berghe, G ;
Weekers, F ;
Baxter, RC ;
Wouters, P ;
Iranmanesh, A ;
Bouillon, R ;
Veldhuis, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3217-3226